Article
The role of dysregulated PI3Kdelta signaling in human autoimmunity*
28 Jan 2022
Abstract excerpt
Better treatment of autoimmune diseases requires an improved understanding of the cellular and molecular mechanisms that lead to the breakdown of immune tolerance. The discovery of individuals with germline mutations in PIK3CD (which encodes the p110δ catalytic subunit of PI3K) has revealed the importance of regulated PI3Kδ activity to maintain tolerance. These patients display a range of symptoms including both...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
